Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

Clinical trial NCT03529877 · COMPLETED

Trial details

NCT number: NCT03529877
Sponsor: RHEACELL GmbH & Co. KG
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recessive Dystrophic Epidermolysis Bullosa

Start date: 2019-02-16
Primary completion: 2021-11-26
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.